With the fluorescence probe of 8-anilino-1-naphthalenesulfonate (ANS), the binding modes of terminally substituted alkane analogues (CnX; X = COOH, OH, CHO, NH3, CONH2) to bovine serum albumin (BSA) were investigated using a competitive binding technique. The Scatchard plot of the fluorometric titration of BSA with ANS showed that the maximum binding number of ANS, nmax, was 3.81, with the binding constant, Kbnd, of 1.42 × 10 6 mol -1 dm 3 . The binding modes of CnX to BSA were analyzed based on the fluorometric titration of the ANS and BSA mixture with CnX. CnCOOH completely displaced the ANS bound to BSA, whereas CnOH and CnCHO displaced only about 40% of the ANS bound to BSA. In contrast, CnNH2 and CnCONH2 displaced very little bound ANS. By comparing these results, we classified the binding modes of CnX to BSA into three types. Two of them are detectable with the ANS fluorescence and the remaining one is not detectable with the fluorescence.
Introduction
8-Anilino-1-naphthalenesulfonate (ANS) fluoresces strongly in hydrophobic solvents but is almost nonfluorescent in water. 1 The fluorescence intensities of the ANS ions bound to proteins are nearly equal to those of ANS ions dissolved in organic solvents. The large increase of the fluorescence intensity of ANS ions, when bound to BSA in water, is attributed to binding to the hydrophobic domains of a protein. [2] [3] [4] We denote these sites as the fluorescence-active sites.
Despite extensive spectrofluorometric studies with ANS, clear understanding of the properties of the binding site in BSA is lacking. Though it is established that there are at least two types of ANS binding sites in a BSA molecule, uncertainties still remain as to the properties of each binding site. [5] [6] [7] [8] Inhalation anesthetics and alcohols are hydrophobic molecules and are considered to act by interacting with a number of proteins by hydrophobic interaction. [9] [10] [11] Therefore, it is important to make clear the binding properties of the hydrophobic molecules to proteins to elucidate the anesthetic action on proteins. This study used spectrofluorometry of the ANS to analyze the binding of five types of alkane analogues, CnX, that is, alkylalcohols (CnOH, n = 8, 10, 12), alkylaldehyde (CnCHO, n = 7, 9, 11), alkylacids (CnCOOH, n = 5, 7, 9, 11), alkylamines (CnNH2, n = 8, 10, 12), and alkylamides (CnCONH2, n = 7, 9, 11). CnCOOH are in anionic form in the aqueous solution of neutral pH, whereas CnNH2 and CnCONH2 are in cationic form in the neutral pH. 12 CnOH and CnCHO have no net charges in the usual pH range. We reported previously that these analogues acted on the protein function in a different manner. 13, 14 We report here the classification of three types of binding sites in a BSA molecule, estimated by the ANS fluorescence. Two of these types are fluorescence-active for the ANS ions bound to BSA, whereas the remaining one is fluorescence-inactive and cannot be detected by the ANS fluorescence. This report will show that the terminal charge of the CnX critically affects the displacement reaction of the ANS ions bound to the fluorescence-active sites in BSA with CnX. [15] [16] [17] Hydrophobicity of the CnX is also suggested to be another key factor to differentiate the binding sites in BSA.
It is demonstrated that the three types of the binding sites in BSA can be classified by the competitive binding measurements of the ANS ions and alkane analogues. [18] [19] [20] 
Experimental

Materials and sample preparation
Essentially fatty acid free bovine serum albumin (Cat. No. A7511) was purchased from Sigma Chemical Co. (St. Louis, USA) and used as supplied. An ammonium salt of 8-anilino-1-naphthalenesulfonic acid (ANS·NH4) was purchased from Tokyo Kasei Kogyo (Tokyo, Japan). Terminally substituted alkane analogues were purchased from Tokyo Kasei Kogyo, Aldrich Chemical Co. (Milwaukee, USA) or Acros Organics (New Jersey, USA) and were used without further purification. Sample solutions were prepared using the water purified by a MiliQ-SP reagent water system. Stock solutions of 5 mg cm -3 BSA and 2 mmol dm -3 ANS were prepared by dissolving BSA and ANS·NH4, respectively, into purified water containing 0.1 mol dm -3 glycylglycine buffer of pH 7.4. The concentrations of BSA and ANS were calibrated by UV/VIS absorbance using the molar absorption coefficient at 280 nm of 4.36 × 10 4 cm -1 mol -1 dm 3 and the molecular weight 65500 for BSA and the molar absorption coefficient at 350 nm of 5.83 × 10 3 cm -1 mol -1 dm 3 for ANS. The absorbance was measured with a Shimadzu RF-2200 UV/VIS spectrophotometer.
The pH values of all sample solutions were adjusted to 7.4 with 0.1 mol dm -3 glycylglycine buffer. For fluorescence measurements, an aliquot of BSA and ANS stock solutions were mixed, diluted to desired concentration and kept standing for at least 15 min at 25˚C to equilibrate the binding reaction before measurements.
Fluorescence measurements
Fluorescence was measured using a Shimadzu RF-5000 fluorescence spectrophotometer equipped with a temperaturecontrolled cell holder. The cell temperature was controlled at 25 ± 0.2˚C by a NESLAB RTE-8 circulation water bath. The excitation wavelength was 352 nm and emission spectra were recorded between 460 nm and 480 nm. The peak wavelengths of the emission spectra were observed at around 471 nm.
To avoid the concentration quenching of the fluorophore, we kept the ANS concentrations below 2 × 10 -5 mol dm -3 . Under this concentration, a linear relationship between the fluorescence intensity and ANS concentration was confirmed by measuring the ANS fluorescence in n-propanol.
The fluorescence quantum yield of the ANS bound to BSA, ANS-BSA, was estimated using quinine sulfate as the standard. The absorbance and fluorescence intensities of ANS-BSA solution were compared to those of quinine sulfate solution. The quantum yield of the quinine sulfate in 1.0 mol dm -3 H2SO4 was taken as 0.55 at 25˚C.
Displacement measurements
The displacement of the ANS on BSA with CnX was estimated by adding an aliquot of CnX solution into the mixture of 0.75 μmol dm 
Results and Discussion
Fluorescence intensity of the ANS bound to BSA
The fluorescence intensity of the ANS-BSA was estimated by the following procedure. Under the ANS concentration fixed at 10.3 μmol dm -3 , the double reciprocal plot between the fluorescence intensity versus the total BSA concentration is shown in Fig. 1 . The maximum fluorescence intensity was obtained by extrapolating the linear regression line to infinite BSA concentration. This value is assigned to the fluorescence intensity of the ANS-BSA under the condition that all ANS ions in solution are bound to the BSA molecules. The molar fluorescence intensity of the ANS on BSA was obtained by dividing the maximum fluorescence intensity of the ANS-BSA by the ANS concentration. The molar fluorescence intensity was converted further to the quantum yield using the quantum yield 0.55 of quinine sulfate as the standard. 21 In these procedures, we assumed that the fluorescence intensities of all bound ANS are equivalent and independent of the binding site in BSA. The quantum yield of the ANS-BSA thus obtained was 0.46, which agrees well with the reported values 0.42 -0.48 for the ANS bound to proteins. 22 This result supports the validity of the assumption of the equivalent fluorescence intensity for all bound ANS ions.
Binding of ANS to BSA
The maximum binding number of ANS to BSA, nmax, and the binding constant, Kbnd, were estimated by the fluorometric titration of 0.74 μmol dm -3 BSA with ANS solution. Figure 2 shows the Scatchard analysis of the titration data. A straight line was obtained with nmax 3.81 and Kbnd 1.42 × 10 6 mol -1 dm 3 . The linearity of the Scatchard plot and the nmax value of 3.81 indicate the existence of four binding sites in a BSA molecule with similar affinity to ANS ions. These values agree well with those reported by several authors, in which nmax and Kbnd values were in the ranges of 3 to 5 and 2.1 × 10 5 to 2.9 × 10 6 , respectively. [23] [24] [25] Even more ANS binding sites on BSA were reported by Kolb and Weber 26 and Valsami. 27 These sites are identified by equilibrium dialysis and potentiometry but not detectable by fluorescence measurement.
Therefore, these sites are considered to be hydrophilic enough that water molecules can 1572 ANALYTICAL SCIENCES DECEMBER 2006, VOL. 22 ) was titrated with BSA to obtain the fluorescence intensity of the ANS bound to BSA (ANS-BSA). The quantum yield of the ANS-BSA obtained from the extrapolation to the infinite BSA concentration was 0.46, based on quinine as the standard. ) was titrated with ANS. The maximum binding number, nmax, and the binding constant, Kbnd, of the ANS to BSA were estimated from the slope and X-axis intercept and were 3.81 and 1.42 × 10 6 , respectively. gain access to the bound ANS ions to quench their fluorescence. Furthermore, the reported binding capacity of these sites is more than ten ANS ions in a BSA molecule, far larger than the capacity of fluorescence-active sites of 3 to 5. Figure 3 shows the fluorescence intensities of the ANS-BSA when C9COOH, C10OH, C9CHO, C10NH2, or C9CONH2 is added to the aqueous solution of 10.3 μmol dm -3 ANS and 0.74 μmol dm -3 BSA mixture at pH 7.4. In Fig. 3 , the relative fluorescence intensity was taken as the fluorescence intensity of the ANS in the presence of CnX divided by the fluorescence intensity in the absence of CnX. These alkane analogues are classified in the three different types depending on the inhibition effect on the ANS fluorescence.
Displacement of the bound ANS with CnX
C9COOH (group-I*) inhibited the fluorescence intensity most effectively. It almost entirely quenched the fluorescence intensity of the ANS-BSA in a dosedependent manner.
In addition, the plot showed two distinguishable segments with the inflection point at the C9COOH concentration about 10 -5 mol dm -3 . C10OH and C9CHO (group-II) inhibited only about 40% of the fluorescence at their highest soluble concentrations. There are two types of the fluorescence-active ANS binding sites in a BSA: one is competitive to group-II alkane analogues, and the other is noncompetitive. C10NH2 and C9CONH2 (group-III) inhibited the fluorescence intensity very little even at their highest soluble concentrations.
Assuming that all the fluorescence-active sites in BSA are occupied by either of ANS or CnX, we estimated the amount of CnX bound to BSA from the decrease of the ANS fluorescence. Figures 4 to 8 show the site occupancies of CnX thus obtained as a function of free CnX concentration for CnCOOH, CnOH, CnCHO, CnNH2, and CnCONH2, respectively.
The site occupancy, θ, is defined as the number of the bound CnX divided by the number of the fluorescence-active binding sites in a BSA. In these figures, the results for the different alkyl chain-length of CnX are also plotted. For all alkane analogues examined, the displacement began to occur at lower CnX concentrations with the increase of the alkyl chain-length.
However, the maximum displacement at higher concentration was almost independent of the alkyl chain-length. All group-I analogues almost entirely displaced the ANS on BSA. Moreover, the binding profiles in Fig. 4 show the inflection point at the occupancy of around 40%. This inflection point, however, faded gradually with the decrease of the alkyl chainlength of CnCOOH. In contrast, all group-II analogues displaced only about 40% of the ANS on BSA, and the remaining 60% of the bound ANS were unaffected. The effects of group-III analogues were not more than 17% of the bound ANS. The results of the group-I and group-II analogues suggest the existence of two different types of the fluorescence-active sites in BSA. These two types of the binding sites in BSA, however, cannot be distinguished by the direct measurement of 1573 ANALYTICAL SCIENCES DECEMBER 2006, VOL. 22 , respectively. C9COOH entirely quenched the fluorescence of ANS-BSA. C10OH and C9CHO decreased the fluorescence intensity about 40% of the initial intensity at their saturated concentrations. C10NH2 and C9CONH2 decreased the fluorescence not more than 20% of the initial intensity. Fig. 4 Dependences of the concentration of free CnCOOH (n = 5, 7, 9, 11) on the site occupancy, θ, of CnCOOH in BSA. The concentrations of ANS and BSA were 10.3 and 0.74 μmol dm -3 , respectively. All of CnCOOH entirely displaced the ANS bound to the fluorescence-active sites in BSA, though the concentration required for the entire displacement increased with decreasing the alkyl chain-length. Moreover, the binding curves can be divided in two segments. We classify the CnCOOH as the group-I analogues.
* We categorize the three types of terminally-substituted alkane analogues as group-I (CnCOOH), group-II (CnOH and CnCHO), and group-III (CnNH2 and XnCONH2). 
in which subscripts 1 and 2 signify two types of the binding sites, site-1 and site-2, in BSA, and η and K are the fraction of each site and the binding constant, respectively. By using the experimental values of θ and [CnXfree], we can estimate the
values of η and K. For group-II and group-III, Eq. (1) is reduced to the following form.
The η and K values obtained from the best fitted curves are listed in Table 1 for group-I and Table 2 for group-II and group-III analogues. From these results, one can conclude that the fractions of 40% and 60% for site-1 and site-2, respectively, are reasonable assignments. The ANS on site-1 can be displaced by both group-I and group-II analogues, whereas the ANS on site-2 can be displaced only by the group-I analogues. Because the number of fluorescence-active binding sites in a BSA was four, as estimated from the Scatchard plot in Fig. 2 , the values of site-1 (40%) and site-2 (60%) correspond to the average number of 1.6 and 2.4 sites, respectively, in a BSA. Two different types of the ANS binding sites were also reported for human serum albumin (HSA) by Bagatolli et al. using phase modulation fluorescence spectroscopy. 6 The fractions of these two sites in a HSA were 31% and 69%, respectively. They also reported that only the ANS molecules bound to site-1 were displaced by other ligand like a diazepam. More importantly, the difference of the binding affinity between the two sites decreased with the decrease of the alkyl chain-length of the CnCOOH as shown in Fig. 4 and Table 1 . This result indicates that the hydrophobicity is also an important factor to differentiate the binding properties of the two types of the binding sites.
In the case of the group-III analogues, both the numbers of the binding sites and the binding constants were lower than those of group-I and group-II analogues. It indicates that the group-III analogues scarcely displaced the ANS ions on BSA at all. However, this does not indicate that these analogues are incapable of interaction with BSA, because a variety of cationic detergents bind to BSA with large binding numbers exceeding 100 ions on a BSA. 28 One possible cause of this lack of displacement may be that cationic alkane analogues do not share the fluorescence-active binding site with anionic ANS ions, but they do bind to the fluorescence-inactive sites in BSA. As reported by Kolb and Weber 26 and Valsami, 27 more than ten fluorescence-inactive ANS binding sites were identified by
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There are three types of ANS binding sites in a BSA molecule, as demonstrated by the competitive binding of three different types of alkane analogues in connection with the results of nonfluorometric techniques. The ANS ions bound to the site-2 of BSA can be displaced only by group-I analogues, whereas the ANS ions on the site-1 can be displaced by the both group-I and group-II analogues but not by group-III analogues. Only the ANS ions bound to the site-3 of BSA can be displaced by the group-III analogues, though such displacement cannot be detected by the ANS fluorescence.
At the present experimental condition of pH 7.4, both ANS and group-I analogues CnCOOH are negatively charged, and group-III analogues CnNH2 and CnCONH2 are positively charged. The group-II analogues CnOH and CnCHO have no net charge. Therefore, one would expect that the electrostatic interaction is one of the key factors to differentiate the three types of the binding sites in BSA. Site-2 has a specific affinity to the negative charges. The ANS ions bound to this site can only be displaced by the negatively charged group-I analogues. In contrast, site-1 has higher affinity to hydrophobicity than to negative charge. The ANS ions bound to this site can be displaced by either group-I or group-II analogues but not by the positively charged group-III analogues. As for the site-3 locations, these sites are considered to be the ionizable side chains of the amino acid residues located at the protein-water interface. Although there are hydrophobic interactions between these sites and ANS ions, the interactions are not as strong as for site-1 and site-2. Therefore, water molecules are easily accessible to the ANS ions bound to the site-3 in BSA, enough to quench the fluorescence. These sites constitute the third binding sites for hydrophobic ligands. This conclusion suggests that the hydrophobic bindings to these sites are not specific. Nonspecific interactions at multiple uncharged and charged sites are candidates for the site-3 in BSA.
As shown in the Scatchard plot in Fig. 2 , the site-1 and site-2 in BSA cannot be differentiated by the binding of ANS to BSA. On the other hand, the differences of the binding interactions in two sites are most explicit at C9COOH and decreased with decreasing the alkyl chain-length, as shown in Fig. 4 . The hydrophobicity of CnCOOH also decreases with decreasing the alkyl chain-length. ANS is more soluble in water than the CnCOOH examined. Therefore, we can conclude that suitable hydrophobicity is required to differentiate the site-1 and site-2 in BSA.
In conclusion, the competitive binding technique using terminally-substituted alkane analogues provides an easy and useful way to classify the binding modes of the hydrophobic small molecules or ions to proteins.
